Look at TRIL to see what a management change can di. They were dead before Jan Svarka took over; old management was inept and brought the share price for a best in class CD47 down to 95% to 0.30$. Then finally the CEO was ousted. Yesterday Svarka completed an oversubscribed raise for 13$ and announced a collaboration with Pfizer.
AMRN management needs to go before anything will change for the share price. As long as JT and his pals are on board noone will believe in a brighter future of this company.
Look at TRIL to see what a management change can di. They were dead before Jan Svarka took over; old management was inept and brought the share price for a best in class CD47 down to 95% to 0.30$. Then finally the CEO was ousted. Yesterday Svarka completed an oversubscribed raise for 13$ and announced a collaboration with Pfizer.
AMRN management needs to go before anything will change for the share price. As long as JT and his pals are on board noone will believe in a brighter future of this company.
News 
Market Data 
Discover 
